Previous 10 | Next 10 |
SAN DIEGO, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARÉ), a leader in women’s health innovation, today announced the closing of the previously announced acquisition by merger of privately-held Microchips Biotech, Inc. As a result of the transac...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid (HA) technology platform , today announced its participation in two upcoming international conferences – the M...
Historically, buying small-cap stocks into year-end has been savvy because of the "January Effect", a period of strong excess performance by small-cap stocks that stretches from mid-December through the following May. Over the past decade, the median return of the iShares Russell 2000 ETF (I...
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company with products leveraging its proprietary hyaluronic acid ("HA") technology platform , today announced plans to showcase its osteoarthritis pain management and joint preservat...
The following slide deck was published by Anika Therapeutics, Inc. in conjunction with their 2019 Q3 earnings Read more ...
Gainers: Xunlei (NASDAQ: XNET ) +61% . Anika Therapeutics (NASDAQ: ANIK ) +36% . Reebonz Holding (NASDAQ: RBZ ) +25% . DMC Global (NASDAQ: BOOM ) +19% . AMAG Pharmaceuticals (NASDAQ: AMAG ) +16% . BJ's Restaurants (NASDAQ: BJRI ) +15% . Vipshop Holdings (NYSE: VIPS ) +15% . ResMed ...
Thinly traded Anika Therapeutics ( ANIK +29.1% ) is up on almost 50% higher volume, albeit on turnover of only 297K shares, after posting better-than-expected Q3 results after the close yesterday that included bullish guidance for the year. Highlights: More news on: Anika Therapeutics,...
Image source: The Motley Fool. Anika Therapeutics Inc (NASDAQ: ANIK) Q3 2019 Earnings Call Oct 24, 2019 , 5:00 p.m. ET Operator Continue reading
Anika Therapeutics Inc. (ANIK) Q3 2019 Earnings Conference Call October 24, 2019 17:00 ET Company Participants Sylvia Cheung - CFO Joseph Darling - President & CEO Conference Call Participants Jim Sidoti - Sidoti & Company Joe Munda - First Analysis Brian Gagnon -...
Anika Therapeutics (NASDAQ: ANIK ): Q3 GAAP EPS of $0.64 beats by $0.25 . More news on: Anika Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Anika Therapeutics Inc. Company Name:
ANIK Stock Symbol:
NASDAQ Market:
Anika Therapeutics Inc. Website:
Integrity and its complete arthroscopic instrumentation platform are now fully available in the U.S., expanding Anika’s proprietary hyaluronic acid (HA) regenerative portfolio Over 300 surgeries completed during the limited market release, highlighting the growing interest and commerci...
2024-07-09 17:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-05-29 13:30:02 ET Stephens analyst issues EQUAL-WEIGHT recommendation for ANIK on May 29, 2024 12:00PM ET. The previous analyst recommendation was Equal-Weight. ANIK was trading at $25.32 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...